Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Medicare Part B
Regulatory
CMS may add Part B drugs to negotiations under draft guidance
The Trump administration has issued new draft guidance for the third cycle of Medicare drug price negotiations.
Paige Minemyer
May 12, 2025 5:36pm
Payer Roundup—Aetna gets warning; Humana collabs with Thyme Care
Mar 3, 2025 11:34am
HHS releases cost savings for 64 prescription drugs
Dec 20, 2024 11:00am
Study: Remote monitoring for heart failure could save CMS money
May 22, 2024 9:00am
HHS releases newest list of inflation-capped Part B drugs
Mar 26, 2024 11:49am
Feds flag 48 drugs subject to rebates under IRA powers
Dec 14, 2023 1:00pm
